Loading company…
Germantown, Maryland-based biotechnology company developing cell therapy for insulin-dependent diabetes.
Founded in 2013 and based in Germantown, Maryland, Seraxis Inc. is a biotechnology company focused on cell therapy for diabetes. William L. Rust is CEO and co-founder, and Carole Welsch is co-founder and chief business officer. In March 2013, the company raised an undisclosed Series A from ASAP Ventures, GRI Fund, L.P. and East West Capital Partners. Its lead candidate, SR-01, is undergoing preclinical testing ahead of planned first-in-human trials.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in